These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 6446394

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clinical trials with cefoperazone in the field of internal medicine in Japan.
    Mashimo K, Kunii O.
    Clin Ther; 1980; 3(Spec Issue):159-72. PubMed ID: 6446392
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Randomized, double-blind, comparative study of levofloxacin and ofloxacin in the treatment of complicated urinary tract infections.
    Peng MY.
    J Microbiol Immunol Infect; 1999 Mar; 32(1):33-9. PubMed ID: 11561568
    [Abstract] [Full Text] [Related]

  • 7. [Clinical trial of HAPA-B in complicated urinary tract infections].
    Kamiryo Y, Kato M, Sanefuji T, Hirao H.
    Hinyokika Kiyo; 1986 Sep; 32(9):1379-85. PubMed ID: 3101447
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Cefoperazone--a new cephalosporin antibiotic with broader spectrum of activity].
    Jendroschek T, Belmega G, Lode H, Kemmerich B, Dzwillo G, Koeppe P, Wagner J.
    Med Klin; 1981 Feb 13; 76(4):102-6, 70. PubMed ID: 6452567
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical experience with T-2588 in complicated urinary tract infections].
    Fukatsu H, Nonomura H, Ohshita H, Miyagawa Y, Hatano Y, Waki M, Takamura T, Hiraiwa S, Yamada Y, Muramatsu T.
    Hinyokika Kiyo; 1986 Jul 13; 32(7):1061-8. PubMed ID: 3776768
    [Abstract] [Full Text] [Related]

  • 14. [Indanyl Carbenicillin in the treatment of urinary tract infections due to difficult urological organisms (author's transl)].
    Popa G, Nuri M, Peters HJ.
    Med Klin; 1976 Jan 16; 71(3):104-9. PubMed ID: 765706
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cefoperazone-sulbactam combination in the treatment of urinary tract infections: efficacy, safety, and effects on coagulation.
    Greenberg RN, Reilly PM, Weinandt WJ, Bollinger M, Kennedy DJ.
    Clin Ther; 1987 Jan 16; 10(1):52-6. PubMed ID: 3329965
    [Abstract] [Full Text] [Related]

  • 17. [Clinical-pharmacological study of the new semi-synthetic penicillin preparation, carbenicillin, in urologic patients. Relations between blood and tissue concentration of carbenicillin].
    Iván E, Földi J, Arr M, Molnár I, Biró L.
    Z Urol Nephrol; 1970 Apr 16; 63(4):241-6. PubMed ID: 4943703
    [No Abstract] [Full Text] [Related]

  • 18. Complicated urinary tract infections treated with cefuroxime or cefazolin: a comparative study.
    Iversen P, Madsen PO.
    Clin Ther; 1981 Apr 16; 4(4):302-7. PubMed ID: 7037184
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Effective treatment of urinary tract infection with carbenicillin].
    Yamamoto C, Miyoshi T, Namikawa K, Fukuchi S.
    Hinyokika Kiyo; 1971 Sep 16; 17(9):596-600. PubMed ID: 5001081
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.